IVF Debuts Trading on mai Market, Confident in Growth Potential Poised to Become a Leading Internationally Accredited Fertility Center in Thailand and Asia

IVF Debuts Trading on mai Market, Confident in Growth Potential Poised to Become a Leading Internationally Accredited Fertility Center in Thailand and Asia

Inspire IVF Public Company Limited (IVF) commenced trading on the Market for Alternative Investment (mai) today under the service industry group. The company is confident in its growth potential, driven by the demand in the fertility industry, and aims to expand into a leading internationally accredited fertility center in Thailand and Asia. This move will strengthen the company’s financial position and cater to the needs of both domestic and international clients.

Miss Kasinee Kuldiloke, Chief Executive Officer, Inspire IVF Public Company Limited (IVF), stated, “Listing on the mai is a significant step for the company, enhancing our business capabilities and creating long-term growth opportunities. The 304 million baht raised will be used to expand branches domestically and internationally, as well as invest in related businesses such as wellness, to enhance service efficiency and generate continuous revenue and profit growth. With 80-90% of our clients being international, a group with high demand for fertility services, we plan to expand our services to meet their needs. IVF offers comprehensive services, from consultation and treatment planning to advanced assisted reproductive technologies like Intracytoplasmic Sperm Injection (ICSI) and Intrauterine Insemination (IUI), supported by a team of expert doctors and scientists.”

IVF’s business is divided into two main segments:

• Fertility Services: This includes Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Testing (PGT), and other fertility treatments.
• Preventive and Restorative Medicine: This wellness-focused approach helps restore health and balance the body’s functions for optimal performance. The service has been offered since 2023.

Following the IPO of 130 million shares at 3.10 baht per share, the company has a registered and paid-up capital of 220 million baht, representing a total offering value of 403 million baht and a market capitalization at IPO of 1,364 million baht. The P/E ratio stands at 44.93, reflecting investor confidence in the company’s growth potential.

” We extend our sincere gratitude to our investors, the mai, the SEC, our financial advisors, and all partners who contributed to the success of our fundraising and listing. We are committed to continuous development to achieve strong and sustainable growth, becoming a leading internationally accredited fertility center in Thailand and Asia. This will enable us to capitalize on the growth of the fertility and wellness industries in the future, supporting business expansion and generating strong returns for our shareholders in the long term,” Kasinee concluded.

Follow Inspire IVF Public Company Limited (IVF) on their website: https://www.inspireivf.com, Facebook page: https://www.facebook.com/inspireivfthailand, or tel. 063-531-8666 and 02-251-8666.